Latest news January , Apellis Reports Positive Top-line Results from Phase Head-to-Head Study of Pegcetacoplan (APL-) Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) January , Apellis Pharmaceuticals to Present at the th Annual J.P. Morgan Healthcare Conference November , ...
apellis.com was registered 1 decade 6 years ago. It has a alexa rank of #690,519 in the world. It is a domain having .com extension. It is estimated worth of $ 1,920.00 and have a daily income of around $ 8.00. As no active threats were reported recently, apellis.com is SAFE to browse.
Daily Unique Visitors: | 1,270 |
Daily Pageviews: | 2,540 |
Income Per Day: | $ 8.00 |
Estimated Worth: | $ 1,920.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 690,519 |
PageSpeed Score: | 74 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Total Traffic: | No Data |
Direct Traffic: | No Data |
Referral Traffic: | No Data |
Search Traffic: | No Data |
Social Traffic: | No Data |
Mail Traffic: | No Data |
Display Traffic: | No Data |
H1 Headings: | 2 | H2 Headings: | 5 |
H3 Headings: | 6 | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | 1 | Total Images: | 9 |
Google Adsense: | Not Applicable | Google Analytics: | UA-88164312-1 |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
for a | 3 | 0.993 % | No |
Apellis Pharmaceuticals | 3 | 0.993 % | No |
a broad | 2 | 0.662 % | No |
range of | 2 | 0.662 % | No |
broad range | 2 | 0.662 % | No |
driven by | 2 | 0.662 % | No |
or excessive | 2 | 0.662 % | No |
Investors Media | 2 | 0.662 % | No |
of the | 2 | 0.662 % | No |
activation of | 2 | 0.662 % | No |
excessive activation | 2 | 0.662 % | No |
uncontrolled or | 2 | 0.662 % | No |
therapies for | 2 | 0.662 % | No |
C3 glomerulopathy | 2 | 0.662 % | No |
at Apellis | 2 | 0.662 % | No |
and compassion | 2 | 0.662 % | No |
We are | 2 | 0.662 % | No |
targeted C3 | 2 | 0.662 % | No |
C3 therapies | 2 | 0.662 % | No |
Contact Us | 2 | 0.662 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
or excessive activation of | 2 | 0.662 % | No |
who is living with | 2 | 0.662 % | No |
uncontrolled or excessive activation | 2 | 0.662 % | No |
excessive activation of the | 2 | 0.662 % | No |
activation of the complement | 2 | 0.662 % | No |
Pharmaceuticals to Present at | 2 | 0.662 % | No |
Apellis Pharmaceuticals to Present | 2 | 0.662 % | No |
driven by uncontrolled or | 2 | 0.662 % | No |
by uncontrolled or excessive | 2 | 0.662 % | No |
for a broad range | 2 | 0.662 % | No |
a broad range of | 2 | 0.662 % | No |
of our company is | 1 | 0.331 % | No |
our company is the | 1 | 0.331 % | No |
is the belief that | 1 | 0.331 % | No |
company is the belief | 1 | 0.331 % | No |
Investor Conferences Newsroom ApellisPharma | 1 | 0.331 % | No |
Conferences Newsroom ApellisPharma At | 1 | 0.331 % | No |
the belief that exceptional | 1 | 0.331 % | No |
the heart of our | 1 | 0.331 % | No |
At the heart of | 1 | 0.331 % | No |
Domain Registrar: | GoDaddy.com, LLC |
---|---|
Registration Date: | 2008-03-08 1 decade 6 years 8 months ago |
Last Modified: | 2017-12-15 6 years 11 months 4 days ago |
Host | IP Address | Country | |
---|---|---|---|
ns05.domaincontrol.com | 97.74.102.3 | United States | |
ns06.domaincontrol.com | 173.201.70.3 | United States |
Host | Type | TTL | Extra |
---|---|---|---|
apellis.com | A | 571 |
IP: 3.230.238.92 |
apellis.com | NS | 3600 |
Target: ns06.domaincontrol.com |
apellis.com | NS | 3600 |
Target: ns05.domaincontrol.com |
apellis.com | SOA | 3600 |
MNAME: ns05.domaincontrol.com RNAME: dns.jomax.net Serial: 2019102201 Refresh: 28800 Retry: 7200 Expire: 604800 |
apellis.com | MX | 600 |
Target: apellis-com.mail.protection.outlook.com |
apellis.com | TXT | 600 |
TXT: v=spf1 include:spf.protection.outlook.com include:mailsenders.netsuite.com include:cvent.com include:cvent-planner.com include:cventmail.com include:cvtsv.com -all |
apellis.com | TXT | 600 |
TXT: google-site-verification=FlAMR79eRMolnlR S_vso6Bnd5uMBqrQdHOApU_zqRQs |
apellis.com | TXT | 600 |
TXT: MS=ms51991334 |
apellis.com | TXT | 600 |
TXT: logmein-verification-code=0bede69f-fc72- 4bad-8814-003ae7ba4473 |
Sakarya günlük yayınlanmakta olan yerel gazeteye ait web sitesi. Adres: Pabuççular Mahallesi Değirmenhan Sk. Vasfiye Aşoğlu İş merkezi No:19 Daire: 6-7-8 Adapazarı / SAKARYA...
Chia sẽ kiến thức tin há»c opensource, Linux, VMware